INTRAugust 6, 2026 at 8:04 PM UTCBanks

Inter & Co Reports Record Q2 2026 Profitability Under Rule of 50 Framework

Read source article

What happened

Inter & Co announced record second-quarter 2026 profitability, driven by revenue growth, higher net interest margins, and operating leverage, aligning with its Rule of 50 framework that combines top-line growth and returns. The strong headline numbers provide an early positive signal for the investment thesis, which had hinged on 2Q-3Q26 data proving that growth quality was stabilizing after 1Q26’s deteriorating credit and monetization metrics. However, the brief earnings call highlights lack specific updates on key concerns—nonperforming loans, net ARPAC, and capital consumption—that determined the prior WAIT rating. Without evidence that 15–90 day NPLs receded from 5.6%, ARPAC rebounded above R$34.1, or Basel improved from 14.0%, the record profit alone does not resolve the thesis’s credit-quality and capital-efficiency risks. The market will likely scrutinize the full Q2 filing for signs that the secured-loan shift and primary-account growth are producing sustainable, low-risk profitability rather than temporary spread-driven earnings.

Implication

The record profitability suggests management’s focus on revenue growth and operating leverage is bearing fruit, potentially moving the stock closer to the bull case if underlying quality matches. However, the prior thesis was WAIT because 1Q26 showed rising NPLs, declining risk-adjusted NIM, and capital consumption, and one quarter of strong profit does not automatically fix these. If the full Q2 details reveal that 15–90 day NPL remained above 5.6% or ARPAC stayed below R$34.1, the improvement would be hollow and the bear case remains dominant. Conversely, a clean quarter with improving asset quality and capital would justify upgrading the rating to a BUY, especially if the secured-loan shift is accelerating. Until the granular Q2 data is available, position sizing should remain measured, using the current rally to trim if near the $7.00 upper bound while awaiting confirmation.

Thesis delta

The record Q2 profit nudges the thesis towards the bull case, but the critical test remains whether earnings quality improved—meaning NPLs, ARPAC, and Basel ratios moved in the right direction. Until the full Q2 filing confirms that growth is not being bought with future provisions, the WAIT rating holds, though conviction edges higher if the preliminary numbers suggest broad-based strength. A decisive shift to BUY would require concrete evidence that the Rule of 50 is being delivered through both revenue growth and durable ROE, not just peak-cycle profitability.

Confidence

Moderate